Gary D. Blackford
Equibles does not estimate personal net worth.
About Gary D. Blackford
Vyome Holdings, Inc reported in an 8-K filed August 19, 2025 that Gary D. Blackford resigned as Board, effective August 15, 2025. Vyome Holdings, Inc reported in an 8-K filed March 20, 2025 that Gary D. Blackford resigned as Board, effective March 15, 2025. Vyome Holdings, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vyome Holdings, Inc includes Andrew Rasdal (CEO), Bart Bandy (CEO), Kelly Huang (CEO) and 7 others.
“Paul Hickey, Dan W. Gladney, Arda M. Minocherhomjee and Lori C. McDougal and Gary D. Blackford resigned from and ceased serving on the Board and any and all committees thereof, which resignations were effective upon the consummation of the Merger.”
“On March 14, 2025, Gary Blackford informed the Board of Directors (the "Board") of ReShape Lifesciences Inc. (the "Company") of his decision to resign from the Board and all related committees effective March 15, 2025.”
Affiliation history
-
Vyome Holdings, Inc (HIND)
SEC 8-K
Current2021-06-15–present
-
2021-06-15–2025-08-15
Company network
Leadership on record at Vyome Holdings, Inc
- Andrew Rasdal CEO
- Bart Bandy CEO
- Kelly Huang CEO
- Paul F. Hickey CEO, Board Member
- Venkat Nelabhotla CEO
- Venkateswarlu Nelabhotla CEO, Board Member
- Dan W. Gladney Chairman
- Krishna Gupta Chairman, Board Member
- Krishna K. Gupta Chairman
- Jerry Leonard CFO, Chief Accounting Officer